Jacobs Bruce N.

EDGAR CIK 0001821074

Kymera Therapeutics, Inc. - KYMR

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CFO
Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($214,219)
-7,035 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/03/2025
03/03/2025
Sell
-7,035 @ $30.45
 ($214,219) 201,886 (-3.37%) Direct